J.M. Collée

Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis

B.A.M. Heemskerk-Gerritsen, Matti A. Rookus, Cora M. Aalfs et al. · International Journal of Cancer · 2014 · 213 citations · Full text

Medicine, Oncology, Breast Oncology +14

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

B.A.M. Heemskerk-Gerritsen, Caroline Seynaeve, C. J. van Asperen et al. · JNCI Journal of the National Cancer Institute · 2015 · 206 citations · Full text

Medicine, Gynecology, Oncology +17

Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis

B.A.M. Heemskerk-Gerritsen, Marian B. E. Menke‐Pluijmers, Agnes Jager et al. · Annals of Oncology · 2013 · 117 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

Mieke Kriege, Antoinette Hollestelle, Agnes Jager et al. · British Journal of Cancer · 2014 · 74 citations · Full text

Medicine, Oncology, Cancer Genetics +16

500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival?

B.A.M. Heemskerk-Gerritsen, Maartje J. Hooning, Agnes Jager et al. · European Journal of Cancer Supplements · 2010 · 12 citations

Medicine, Genetics, Oncology +17